The Cost-effectiveness of Valganciclovir Prophylaxis Versus Preemptive Therapy in CMV R+ Kidney Transplant Recipients Over the First Year Posttransplantation

Background. In kidney transplant recipients with positive serology (R+) for the cytomegalovirus (CMV), 2 strategies are used to prevent infection, whose respective advantages over the other are still debated. This study aimed to evaluate the cost-effectiveness and cost utility of antiviral prophylax...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Claire Villeneuve, PhD, Jean-Phillipe Rerolle, MD, Lionel Couzi, MD, PhD, Pierre-Francois Westeel, MD, Isabelle Etienne, MD, Laure Esposito, MD, Nassim Kamar, MD, PhD, Mathias Büchler, MD, PhD, Antoine Thierry, MD, PhD, Pierre Marquet, MD, PhD, Caroline Monchaud, PharmD, PhD
Format:	Artigo
Sprog:	Inglês
Udgivet:	Wolters Kluwer 2024-08-01
Serier:	Transplantation Direct
Online adgang:	http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001678
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!